Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
Vita Life Sciences Dividend Announcement
• Vita Life Sciences announced a semi annually dividend of A$0.04 per ordinary share which will be made payable on 2024-10-04. Ex dividend date: 2024-09-20
• Vita Life Sciences annual dividend for 2024 was A$0.10
• Vita Life Sciences annual dividend for 2023 was A$0.06
• Vita Life Sciences's trailing twelve-month (TTM) dividend yield is 4.59%
• Vita Life Sciences's payout ratio for the trailing twelve months (TTM) is 51.96%
• Vita Life Sciences's dividend growth over the last five years (2018-2023) was 10.76% year
• Vita Life Sciences's dividend growth over the last ten years (2013-2023) was 14.07% year
Vita Life Sciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-20 | A$0.04 | semi annually | 2024-10-04 |
2024-03-22 | A$0.06 | semi annually | |
2023-09-22 | A$0.03 | semi annually | 2023-10-06 |
2023-03-17 | A$0.03 | semi annually | 2023-04-14 |
2022-09-23 | A$0.03 | semi annually | 2022-10-07 |
2022-03-18 | A$0.03 | semi annually | 2022-04-07 |
2021-09-23 | A$0.03 | semi annually | 2021-10-08 |
2021-03-19 | A$0.03 | semi annually | 2021-04-07 |
2020-09-24 | A$0.01 | semi annually | 2020-10-09 |
2020-03-19 | A$0.02 | semi annually | 2020-04-03 |
2019-09-24 | A$0.01 | semi annually | 2019-10-08 |
2019-03-20 | A$0.02 | semi annually | 2019-04-05 |
2018-09-24 | A$0.01 | semi annually | 2018-10-08 |
2018-03-19 | A$0.02 | semi annually | 2018-03-29 |
2017-09-21 | A$0.01 | semi annually | 2017-10-05 |
2017-03-16 | A$0.02 | semi annually | 2017-03-23 |
2016-09-21 | A$0.01 | semi annually | 2016-09-30 |
2016-03-17 | A$0.02 | semi annually | 2016-03-24 |
2015-09-15 | A$0.01 | semi annually | 2015-09-24 |
2015-03-17 | A$0.02 | semi annually | 2015-03-26 |
2014-09-16 | A$0.01 | semi annually | 2014-09-25 |
2014-03-17 | A$0.02 | semi annually | 2014-03-28 |
2013-09-16 | A$0.01 | semi annually | 2013-09-27 |
2013-03-08 | A$0.01 | semi annually | 2013-03-28 |
Vita Life Sciences Dividend per year
Vita Life Sciences Dividend growth
Vita Life Sciences Dividend Yield
Vita Life Sciences current trailing twelve-month (TTM) dividend yield is 4.59%. Interested in purchasing Vita Life Sciences stock? Use our calculator to estimate your expected dividend yield:
Vita Life Sciences Financial Ratios
Vita Life Sciences Dividend FAQ
Other factors to consider when evaluating Vita Life Sciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Vita Life Sciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Vita Life Sciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Vita Life Sciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Vita Life Sciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Vita Life Sciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Vita Life Sciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Vita Life Sciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Vita Life Sciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Vita Life Sciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Vita Life Sciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.